Cargando…
Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees
BACKGROUND: Prior studies have found that patients taking single-pill amlodipine/atorvastatin (SPAA) have greater likelihood of adherence at 6 months than those taking 2-pill calcium-channel blocker and statin combinations (CCB/statin). This study examines whether this adherence benefit results in f...
Autores principales: | Chapman, Richard H, Yeaw, Jason, Roberts, Craig S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897772/ https://www.ncbi.nlm.nih.gov/pubmed/20565779 http://dx.doi.org/10.1186/1471-2261-10-29 |
Ejemplares similares
-
Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study
por: Wang, Yi-Chun, et al.
Publicado: (2016) -
Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007) -
Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?
por: Chapman, Richard H, et al.
Publicado: (2009) -
An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015) -
Statin, Calcium Channel Blocker and Beta Blocker Therapy May Decrease the Incidence of Tuberculosis Infection in Elderly Taiwanese Patients with Type 2 Diabetes
por: Lee, Mei-Yueh, et al.
Publicado: (2015)